The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•16 April 2026•

1 min read

LifeVantage Names Terrence Moorehead as New CEO Effective August 2026

Logos of Mineralys Therapeutics and Jefferies on an orange background with financial charts, chemical structures, microscopes, lab equipment, vials, and pills.

Key Facts

1LifeVantage announced the appointment of Terrence Moorehead as the new President, CEO, and Board member.

2Moorehead is set to officially begin his role on August 5, 2026, following the completion of prior contractual commitments.

LifeVantage Corporation (LFVN) has officially announced the appointment of Terrence Moorehead as its new President, Chief Executive Officer, and member of the Board of Directors. Moorehead is scheduled to formally assume his leadership responsibilities on August 5, 2026, following the conclusion of his current contractual obligations. This executive transition aims to strengthen the company's position within the health, wellness, and cellular activation industry. The appointment is viewed as a strategic move to ensure long-term stability and sustainable growth under fresh leadership. Market participants are closely monitoring this transition to assess the future strategic direction Moorehead will implement. Currently, the impact remains neutral as the market awaits further details on the new CEO's execution plan.